Results 131 to 140 of about 4,426 (152)

Dalteparin

2007
openaire   +1 more source

The effect of body weight on dalteparin pharmacokinetics A preliminary study

European Journal of Clinical Pharmacology, 2000
Stephen Duffull
exaly  

Antepartum dalteparin versus no antepartum dalteparin for the prevention of pregnancy complications in pregnant women with thrombophilia (TIPPS): a multinational open-label randomised trial

Lancet, The, 2014
Joanne Said, Marc Rodger, Mark C Walker
exaly  

Apixaban and dalteparin in active malignancy associated venous thromboembolism

Thrombosis and Haemostasis, 2017
Stanislav Henkin, Charles L Loprinzi, Robert D McBane   +2 more
exaly  

Randomized clinical trial of postoperative fondaparinux versus perioperative dalteparin for prevention of venous thromboembolism in high-risk abdominal surgery

British Journal of Surgery, 2005
Giancarlo Agnelli, Alexander Cohen, Michael Gent   +2 more
exaly  

Thromboprophylaxis with Low Molecular Weight Heparin (Dalteparin) in Pregnancy

Thrombosis Research, 1999
Ville Pettilä, Risto J Kaaja, Eero Ikkala   +2 more
exaly  

Peak Antifactor Xa Activity Produced by Dalteparin Treatment in Patients with Renal Impairment Compared with Controls

Pharmacotherapy, 2005
Henny H Billett, Hillel W. Cohen, Angela Cheng-Lai   +2 more
exaly  

A multicentre comparison of once-daily subcutaneous dalteparin (low molecular weight heparin) and continuous intravenous heparin in the treatment of deep vein thrombosis

Journal of Internal Medicine, 1996
C Hallert
exaly  

Dalteparin for the prevention of recurrence of placental-mediated complications of pregnancy in women without thrombophilia: a pilot randomized controlled trial

Journal of Thrombosis and Haemostasis, 2009
Marc Rodger, Line Leduc, S R Kahn
exaly  

Effect of dalteparin and radiation on survival and thromboembolic events in glioblastoma multiforme: a phase II ECOG trial

Cancer Chemotherapy and Pharmacology, 2007
Minesh Mehta, Mark R Gilbert, Anne O'Neill   +2 more
exaly